A Mutation in Human Immunodeficiency Virus Type 1 Protease, N88S, That Causes In Vitro Hypersensitivity to Amprenavir

Podobne zapisy

• Nelfinavir-Resistant, Amprenavir-Hypersusceptible Strains of Human Immunodeficiency Virus Type 1 Carrying an N88S Mutation in Protease Have Reduced Infectivity, Reduced Replication Capacity, and Reduced Fitness and Process the Gag Polyprotein Precursor Aberrantly
  od: Resch, Wolfgang, i wsp.
  Wydane: (2002)
• Altered Substrate Specificity of Drug-Resistant Human Immunodeficiency Virus Type 1 Protease
  od: Dauber, Deborah S., i wsp.
  Wydane: (2002)
• Activities of Atazanavir (BMS-232632) against a Large Panel of Human Immunodeficiency Virus Type 1 Clinical Isolates Resistant to One or More Approved Protease Inhibitors
  od: Colonno, Richard J., i wsp.
  Wydane: (2003)
• Structural and Kinetic Analyses of the Protease from an Amprenavir-Resistant Human Immunodeficiency Virus Type 1 Mutant Rendered Resistant to Saquinavir and Resensitized to Amprenavir
  od: Markland, W., i wsp.
  Wydane: (2000)
• Phenotypic Hypersusceptibility to Multiple Protease Inhibitors and Low Replicative Capacity in Patients Who Are Chronically Infected with Human Immunodeficiency Virus Type 1
  od: Martinez-Picado, Javier, i wsp.
  Wydane: (2005)